Diagnosis, Pathological Findings, and Clinical Management of Gangliocytic Paraganglioma: A Systematic Review

Background: Although gangliocytic paraganglioma (GP) is considered a rare benign neuroendocrine tumor, cases of mortality have been reported. Occasionally, GP is misdiagnosed as neuroendocrine tumor G1, which is associated with a poorer prognosis than GP. To avoid such misdiagnoses, it is important...

Descripción completa

Detalles Bibliográficos
Autores principales: Okubo, Yoichiro, Yoshioka, Emi, Suzuki, Masaki, Washimi, Kota, Kawachi, Kae, Kameda, Yoichi, Yokose, Tomoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072869/
https://www.ncbi.nlm.nih.gov/pubmed/30101131
http://dx.doi.org/10.3389/fonc.2018.00291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072869/
https://www.ncbi.nlm.nih.gov/pubmed/30101131
http://dx.doi.org/10.3389/fonc.2018.00291

Ejemplares similares